Mimedx (MDXG) Total Debt Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.12% |
| Dec 31, 2025 | -17.74% |
| Sep 30, 2025 | -17.49% |
| Jun 30, 2025 | -22.31% |
| Mar 31, 2025 | -22.18% |
| Dec 31, 2024 | -22.10% |
| Sep 30, 2024 | -22.01% |
| Jun 30, 2024 | -21.09% |
| Jun 30, 2022 | 22.44% |
| Mar 31, 2022 | 40.73% |
| Dec 31, 2021 | 42.26% |
| Sep 30, 2021 | 37.86% |
| Jun 30, 2021 | 37.80% |
| Jun 30, 2017 | 53.80% |
| Mar 31, 2017 | 37.49% |
| Dec 31, 2016 | 27.78% |
| Sep 30, 2016 | 50.03% |
| Jun 30, 2016 | 316.38% |